Dopamine and Sensorimotor Function in Stuttering

PHASE1RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Stuttering, Adult
Interventions
DRUG

Aripiprazole 10 MG

The effects of aripiprazole on stuttering and various behavioral and neural outcomes will be studied compared to placebo.

DRUG

Placebo

Placebo will be compared against aripiprazole for effect on stuttering and various behavioral and neural markers.

Trial Locations (1)

94143

RECRUITING

Biomagentic Imaging Lab, San Francisco

All Listed Sponsors
collaborator

National Institute on Deafness and Other Communication Disorders (NIDCD)

NIH

collaborator

University of Washington

OTHER

lead

University of California, San Francisco

OTHER

NCT07215884 - Dopamine and Sensorimotor Function in Stuttering | Biotech Hunter | Biotech Hunter